Halozyme Therapeutics Inc (NASDAQ:HALO)

17.35
Delayed Data
As of May 29
 -0.33 / -1.87%
Today’s Change
7.51
Today|||52-Week Range
18.18
+79.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues18.4M14.6M30.4M18.7M
 
 
 
 
 
Cost of Goods Sold5.5M4.7M5.7M6.1M
 
 
 
 
 
Depreciation And Amortization443.0K464.0K458.0K421.0K
 
 
 
 
 
 
Operating ExpensesGross Income12.5M9.5M24.2M12.2M
 
 
 
 
 
General Expenses27.4M28.5M28.1M26.1M
 
 
 
 
 
Research And Development18.6M19.9M19.7M16.7M
 
 
 
 
 
Total Operating Expenses33.3M33.6M34.2M32.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.9M-19.0M-3.9M-13.9M
 
 
 
 
 
Interest Expense On Debt1.5M1.4M1.4M1.3M
 
 
 
 
 
Other Expenses0.000.00-45.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.3M-20.3M-5.3M-15.1M
 
 
 
 
 
Net Income-16.3M-20.3M-5.3M-15.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS123.7M124.0M124.3M125.3M
 
 
 
 
 
Shares To Calculate EPS Diluted123.7M124.0M124.3M125.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.16-$0.04-$0.12
 
 
 
 
 
EPS Diluted-$0.13-$0.16-$0.04-$0.12
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account